Literature DB >> 20392918

Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations.

Jason E Bowling1, Aaron E Owens, M Leticia McElmeel, Letitia C Fulcher, Monica L Herrera, Brian L Wickes, James H Jorgensen.   

Abstract

This study assessed an erythromycin-clindamycin (ERY-CC) broth test for inducible CC resistance in beta-hemolytic streptococci. One hundred one isolates of groups A, B, C, F, and G were tested by the CLSI broth microdilution method. Combinations of 1 and 0.25 microg/ml or 0.5 and 0.25 microg/ml of ERY and CC, respectively, detected all inducible isolates.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20392918      PMCID： PMC2884503          DOI： 10.1128/JCM.00663-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  MLS resistance phenotypes and mechanisms in beta-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain.

Authors:  A Portillo; M Lantero; I Olarte; F Ruiz-Larrea; C Torres
Journal:  J Antimicrob Chemother       Date:  2001-01       Impact factor: 5.790

2.  Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

Authors:  D De Mouy; J D Cavallo; R Leclercq; R Fabre
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.

Authors:  M Reig; J Galan; F Baquero; J C Perez-Diaz
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.

Authors:  Sandra S Richter; Kristopher P Heilmann; Susan E Beekmann; Norma J Miller; Ashley L Miller; Cassie L Rice; Christopher D Doern; Sean D Reid; Gary V Doern
Journal:  Clin Infect Dis       Date:  2005-09-01       Impact factor: 9.079

5.  Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

Authors:  James S Lewis; James H Jorgensen
Journal:  Clin Infect Dis       Date:  2004-12-21       Impact factor: 9.079

Review 6.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

7.  Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.

Authors:  M K York; L Gibbs; F Perdreau-Remington; G F Brooks
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.

Authors:  Athanasios G Michos; Chrysanthi G Bakoula; Maria Braoudaki; Foteini I Koutouzi; Eleftheria S Roma; Anastasia Pangalis; Georgia Nikolopoulou; Elena Kirikou; Vassiliki P Syriopoulou
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-22       Impact factor: 2.803

9.  Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci.

Authors:  Patti M Raney; Fred C Tenover; Roberta B Carey; John E McGowan; Jean B Patel
Journal:  Diagn Microbiol Infect Dis       Date:  2006-03-20       Impact factor: 2.803

10.  Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells.

Authors:  Jana M Swenson; William B Brasso; Mary Jane Ferraro; Dwight J Hardy; Cynthia C Knapp; Linda K McDougal; L Barth Reller; Helio S Sader; Dee Shortridge; Robert Skov; Melvin P Weinstein; Barbara L Zimmer; Jean B Patel
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948
View more
  5 in total

Review 1.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

2.  Collaborative evaluation of an erythromycin-clindamycin combination well for detection of inducible clindamycin resistance in beta-hemolytic streptococci by use of the CLSI broth microdilution method.

Authors:  James H Jorgensen; M Leticia McElmeel; Letitia C Fulcher; Lesley McGee; Sandra S Richter; K P Heilmann; Mary Jane Ferraro; Jean Spargo; Anita Glennen
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

3.  Evaluation of disk approximation and single-well broth tests for detection of inducible clindamycin resistance in Streptococcus pneumoniae.

Authors:  James H Jorgensen; M Leticia McElmeel; Letitia C Fulcher; Lesley McGee; Anita Glennen
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

Review 4.  Secondary plant metabolites as potent drug candidates against antimicrobial-resistant pathogens.

Authors:  Kadiatou Keita; Charles Darkoh; Florence Okafor
Journal:  SN Appl Sci       Date:  2022-07-08

5.  Molecular Characterization of Bacterial Isolates from Soil Samples and Evaluation of their Antibacterial Potential against MDRS.

Authors:  Shahida Sadiqi; Muhammad Hamza; Farooq Ali; Sadia Alam; Qismat Shakeela; Shehzad Ahmed; Asma Ayaz; Sajid Ali; Saddam Saqib; Fazal Ullah; Wajid Zaman
Journal:  Molecules       Date:  2022-09-23       Impact factor: 4.927
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.